ONCOSEC MEDICAL INCORPORATED: 10-Q filed 2017-03-16

Name: ONCOSEC MEDICAL INCORPORATED: 10-Q filed 2017-03-16
Creator: ONCOSEC MEDICAL INCORPORATED
License: https://creativecommons.org/licenses/by/4.0/

What ONCOSEC MEDICAL INCORPORATED reported in its quarterly report filed 2017-03-16 (fiscal Q2 2017): 28 published measures, 65 facts as tagged in accession 0001493152-17-002505.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-03-16
Fiscal period: fiscal Q2 2017
Accession: 0001493152-17-002505 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ONCOSEC MEDICAL INCORPORATED filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-01-31	24,307,910	USD
At 2016-07-31	32,406,647	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-01-31	4,606,984	USD
At 2016-07-31	4,353,543	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-01-31	19,700,926	USD
At 2016-07-31	28,053,104	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-01-31	20,541,455	USD
At 2016-07-31	28,746,224	USD
At 2016-01-31	28,845,271	USD
At 2015-07-31	32,035,264	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-11-01 to 2017-01-31	-5,387,311	USD	92
2016-08-01 to 2017-01-31	-10,990,894	USD	184
2015-11-01 to 2016-01-31	-7,037,720	USD	92
2015-08-01 to 2016-01-31	-14,075,111	USD	184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-08-01 to 2017-01-31	9,578	USD	184
2015-08-01 to 2016-01-31	1,060,910	USD	184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-01-31	-84,485,552	USD
At 2016-07-31	-73,494,657	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2016-08-01 to 2017-01-31	1,391	USD	184
2015-08-01 to 2016-01-31	2,172	USD	184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-01-31	2,589,063	USD
At 2016-07-31	2,799,930	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2016-08-01 to 2017-01-31	2,596,280	USD	184
2015-08-01 to 2016-01-31	3,030,225	USD	184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-01-31	21,335,067	USD
At 2016-07-31	29,417,408	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-01-31	3,413,754	USD
At 2016-07-31	3,466,251	USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-01-31	19,734,645	shares
At 2016-07-31	18,036,263	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-01-31	91,196,781	USD
At 2016-07-31	88,233,965	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2017-01-31	14	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2017-01-31	19,700,926	USD
At 2016-07-31	28,053,104	USD
At 2016-01-31	28,592,330	USD
At 2015-07-31	32,695,621	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2017-01-31	3,221,783	USD
At 2016-07-31	3,243,611	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2017-01-31	632,720	USD
At 2016-07-31	443,681	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2017-01-31	383,780	USD
At 2016-07-31	189,309	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2017-01-31	1,193,230	USD
At 2016-07-31	887,292	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2017-01-31	793,612	USD
At 2016-07-31	671,184	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2016-11-01 to 2017-01-31	-5,387,311	USD	92
2016-08-01 to 2017-01-31	-10,989,503	USD	184
2015-11-01 to 2016-01-31	-7,037,720	USD	92
2015-08-01 to 2016-01-31	-14,072,939	USD	184

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2008-08-08 to 2017-01-31	-84,500,000	USD	3099

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2016-11-01 to 2017-01-31	2,504,700	USD	92
2016-08-01 to 2017-01-31	5,007,152	USD	184
2015-11-01 to 2016-01-31	2,924,138	USD	92
2015-08-01 to 2016-01-31	6,300,044	USD	184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2016-11-01 to 2017-01-31	94,000	USD	92
2016-08-01 to 2017-01-31	86,000	USD	184
2015-11-01 to 2016-01-31	189,000	USD	92
2015-08-01 to 2016-01-31	152,000	USD	184

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2016-08-01 to 2017-01-31	189,039	USD	184
2015-08-01 to 2016-01-31	151,601	USD	184

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2016-08-01 to 2017-01-31	1,391	USD	184
2015-08-01 to 2016-01-31	2,172	USD	184

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2016-08-01 to 2017-01-31	25,615	USD	184

Inspect the source

Entity: ONCOSEC MEDICAL INCORPORATED / CIK 0001444307
Captured: 2026-09-22 19:49 UTC
SEC response SHA-256: 326bcab6a98b5e6098a865fe967c999ac8b3247d9466d112c5306da6df2f5607

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001444307.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))